The software automation technology provider has agreed to be taken over by Perforce having raised $127m from investors including Alphabet, Cisco and VMWare.
Month: April 2022
Bakrie acts on $30m Quantum Ventures fund
Quamntum Ventures’ debut fund is anchored by conglomerate Bakrie & Brothers and has so far built up a five-strong portfolio.
Daily Deal Round Up: April 12, 2022
Recombinant protein technology provider Healthgen netted over $87m while shared living space provider Hmlet is buying corporate-backed peer Habyt and Uniswap Labs is launching an investment vehicle.
SoftBank to spin off Latin America fund
The corporate’s Latin America fund will transition to an independent vehicle called Upload Ventures which will invest approximately $100m each year.
Epic Games scores $2bn in corporate funding
Sony and Lego owner Kirkbi each supplied $1bn in funding for the video game publisher and technology provider, valuing it at $31.5bn.
Enerkem pumps in $202m
Repsol led the waste-to-biofuel technology provider’s largest round in four years and plans to collaborate with it on Iberian projects.
Viz.ai gets another visit from GV in $100m round
GV returned for the brain scanning technology provider’s series D round at a $1.2bn valuation, boosting its overall funding to about $250m.
Nord Security raises $100m in first external round
Burda Principal Investments was among the participants that backed the virtual private network provider at a $1.6bn valuation.
Daily Deal Round Up: April 11, 2022
Creo Capital and Legend Capital helped energy storage system developer MS Energy raise an eight-digit sum while Truora and Medfin each received $15m in corporate-backed rounds.
Olson exits GV
Jodi Olson has reportedly left Alphabet’s early-stage investment arm, where she had been a communications and marketing partner for roughly a decade.
BostonGene sequences $150m series B round
The oncology analytics software developer received a top-up from investors including NEC Corporation at a unicorn valuation.
Improbable imports $150m in funding
SoftBank Vision Fund 2 co-led a $150m round to allow the metaverse technology developer to push its overall funding past $750m.
Triana Biomedicines emerges with $110m
Pfizer Ventures was among the investors in Triana’s series A round and has taken a board seat at the molecular glue platform developer.
HilleVax to attack public markets
The Takeda spinoff is developing a vaccine for acute gastroenteritis caused by norovirus infection, and raised about $140m in August 2021.